Arterial cutaneous femoral fistulous tract closure using surgiflo hemostatic matrix: A novel adjunct for post-tavr access-site management

Eileen Gajo, Omer Iftikhar, Paul J. Pearson, Ted Feldman, Mayra Guerrero, Justin Levisay, Michael H. Salinger

Research output: Contribution to journalArticle

Abstract

Several options are available to address hemostasis at the end of a cardiac catheterization or percutaneous transfemoral transcatheter aortic valve replacement (TAVR) when conventional options are ineffective. To date, there have been few studies exploring the use of a topical thrombin preparation, as one of its main contraindications is that it cannot be used intravascularly due to risk of embolization. The following case shows safe utilization of Surgiflo hemostatic gel matrix under fluoroscopic guidance against an inflated balloon in order to achieve closure of a fistulous tract from a femoral artery access site during percutaneous TAVR.

Original languageEnglish (US)
Pages (from-to)277-279
Number of pages3
JournalJournal of Invasive Cardiology
Volume29
Issue number8
StatePublished - Aug 1 2017
Externally publishedYes

Fingerprint

Hemostatics
Thigh
Skin
Femoral Artery
Cardiac Catheterization
Hemostasis
Thrombin
Gels
Transcatheter Aortic Valve Replacement

Keywords

  • access-site management
  • embolization
  • hemostasis

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

Arterial cutaneous femoral fistulous tract closure using surgiflo hemostatic matrix : A novel adjunct for post-tavr access-site management. / Gajo, Eileen; Iftikhar, Omer; Pearson, Paul J.; Feldman, Ted; Guerrero, Mayra; Levisay, Justin; Salinger, Michael H.

In: Journal of Invasive Cardiology, Vol. 29, No. 8, 01.08.2017, p. 277-279.

Research output: Contribution to journalArticle

Gajo, Eileen ; Iftikhar, Omer ; Pearson, Paul J. ; Feldman, Ted ; Guerrero, Mayra ; Levisay, Justin ; Salinger, Michael H. / Arterial cutaneous femoral fistulous tract closure using surgiflo hemostatic matrix : A novel adjunct for post-tavr access-site management. In: Journal of Invasive Cardiology. 2017 ; Vol. 29, No. 8. pp. 277-279.
@article{d601e8df4d3d4c49b4a6c1adc517ad35,
title = "Arterial cutaneous femoral fistulous tract closure using surgiflo hemostatic matrix: A novel adjunct for post-tavr access-site management",
abstract = "Several options are available to address hemostasis at the end of a cardiac catheterization or percutaneous transfemoral transcatheter aortic valve replacement (TAVR) when conventional options are ineffective. To date, there have been few studies exploring the use of a topical thrombin preparation, as one of its main contraindications is that it cannot be used intravascularly due to risk of embolization. The following case shows safe utilization of Surgiflo hemostatic gel matrix under fluoroscopic guidance against an inflated balloon in order to achieve closure of a fistulous tract from a femoral artery access site during percutaneous TAVR.",
keywords = "access-site management, embolization, hemostasis",
author = "Eileen Gajo and Omer Iftikhar and Pearson, {Paul J.} and Ted Feldman and Mayra Guerrero and Justin Levisay and Salinger, {Michael H.}",
year = "2017",
month = "8",
day = "1",
language = "English (US)",
volume = "29",
pages = "277--279",
journal = "Journal of Invasive Cardiology",
issn = "1042-3931",
publisher = "HMP Communications",
number = "8",

}

TY - JOUR

T1 - Arterial cutaneous femoral fistulous tract closure using surgiflo hemostatic matrix

T2 - A novel adjunct for post-tavr access-site management

AU - Gajo, Eileen

AU - Iftikhar, Omer

AU - Pearson, Paul J.

AU - Feldman, Ted

AU - Guerrero, Mayra

AU - Levisay, Justin

AU - Salinger, Michael H.

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Several options are available to address hemostasis at the end of a cardiac catheterization or percutaneous transfemoral transcatheter aortic valve replacement (TAVR) when conventional options are ineffective. To date, there have been few studies exploring the use of a topical thrombin preparation, as one of its main contraindications is that it cannot be used intravascularly due to risk of embolization. The following case shows safe utilization of Surgiflo hemostatic gel matrix under fluoroscopic guidance against an inflated balloon in order to achieve closure of a fistulous tract from a femoral artery access site during percutaneous TAVR.

AB - Several options are available to address hemostasis at the end of a cardiac catheterization or percutaneous transfemoral transcatheter aortic valve replacement (TAVR) when conventional options are ineffective. To date, there have been few studies exploring the use of a topical thrombin preparation, as one of its main contraindications is that it cannot be used intravascularly due to risk of embolization. The following case shows safe utilization of Surgiflo hemostatic gel matrix under fluoroscopic guidance against an inflated balloon in order to achieve closure of a fistulous tract from a femoral artery access site during percutaneous TAVR.

KW - access-site management

KW - embolization

KW - hemostasis

UR - http://www.scopus.com/inward/record.url?scp=85026524758&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026524758&partnerID=8YFLogxK

M3 - Article

C2 - 28756421

AN - SCOPUS:85026524758

VL - 29

SP - 277

EP - 279

JO - Journal of Invasive Cardiology

JF - Journal of Invasive Cardiology

SN - 1042-3931

IS - 8

ER -